Cargando…
Metformin and breast and gynecological cancer risk among women with diabetes
OBJECTIVE: We investigated if metformin lowers breast, endometrial, and ovarian cancer risk in women with type 2 diabetes mellitus compared with women who used other antidiabetic medications. RESEARCH DESIGN AND METHODS: We followed a cohort of 66 778 female patients with diabetes for a maximum of 1...
Autores principales: | Soffer, Diana, Shi, Jiaxiao, Chung, Joanie, Schottinger, Joanne E, Wallner, Lauren P, Chlebowski, Rowan T, Lentz, Scott E, Haque, Reina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316195/ https://www.ncbi.nlm.nih.gov/pubmed/25664181 http://dx.doi.org/10.1136/bmjdrc-2014-000049 |
Ejemplares similares
-
Sleep medication use and risk of fractures in breast cancer survivors
por: Haque, Reina, et al.
Publicado: (2021) -
Health Beliefs Associated With Metformin Use Among Insured Adults With Prediabetes
por: McEwen, Laura N., et al.
Publicado: (2022) -
Association of vitamin B(12) deficiency in people with type 2 diabetes on metformin and without metformin: a multicenter study, Karachi, Pakistan
por: Miyan, Zahid, et al.
Publicado: (2020) -
Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine
por: Tuot, Delphine S., et al.
Publicado: (2015) -
Metformin Use in Prediabetes Among U.S. Adults, 2005–2012
por: Tseng, Eva, et al.
Publicado: (2017)